Last reviewed · How we verify
High dose RX-af01
At a glance
| Generic name | High dose RX-af01 |
|---|---|
| Also known as | Toripalimab |
| Sponsor | Sun Yat-sen University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of RX-af01 Combined With PD-1 Antibody (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |